A randomised controlled trial to evaluate the effectiveness of zoledronate therapy in osteonecrosis of the hip.

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/632548

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Osteonecrosis of the hip is an important cause of musculoskeletal disability and finding therapeuticsolutions has proven to be challenging. A wide range of surgical treatments with variable success rates ahve been proposed for the treatment. Non-surgical treatment options are limited and usually result in a poor prognosis. This novel clinical trial research will study the protective value of a bisphosphonate in patients with osteonecrosis of the hip and evaluate the cost-effectiveness.

Funded Activity Details

Start Date: 01-01-2010

End Date: 01-01-2015

Funding Scheme: Project Grants

Funding Amount: $535,441.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Rheumatology and Arthritis

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

Bisphosphonates | Double-blind randomised trial | Osteonecrosis | Osteonecrosis of the hip | Preventing collapse femoral head | Rheumatology

Related Links